Autistic disorder Trials in Indianapolis, United States
Conditions / Autistic disorder / Indianapolis, United States
Autistic disorder is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01086475 | D-Cycloserine and Social Skills Training in Autism Spectrum Disorders | COMPLETED | PHASE3 |
| NCT01592747 | Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine | COMPLETED | PHASE2 |
| NCT01592773 | Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) | TERMINATED | PHASE2 |
| NCT01592786 | An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) | COMPLETED | PHASE2 |
| NCT01050582 | A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children | COMPLETED | PHASE4 |
| NCT01431326 | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | COMPLETED | — |
| NCT00005014 | Treatment of Autism in Children and Adolescents | COMPLETED | PHASE3 |
| NCT00453180 | A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders | COMPLETED | PHASE2 |
| NCT00110708 | Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism | UNKNOWN | PHASE2 |
| NCT00025779 | Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders | COMPLETED | NA |